PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Apr-2021 New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young as 6 years Sanofi
28-Apr-2021 Ergomed expands operations in Japan Ergomed
28-Apr-2021 Tiziana Life Sciences to participate in a Fireside Chat on 28 April 2021 at 10:30 a.m. EDT Tiziana Life Sciences
28-Apr-2021 Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease Verona Pharma
28-Apr-2021 MPH Health Care AG: Preliminary IFRS result 2020 MPH Health Care AG
28-Apr-2021 British Sickle Cell Disease Patient Shares Her Experience of advanced medical therapy in new MedTech Europe Series Terumo Blood and Cell Technologies
28-Apr-2021 Asher Biotherapeutics Contracts ProBioGen to Develop and Manufacture Their Lead Candidate ProBioGen AG
28-Apr-2021 STORM Therapeutics publishes data in Nature showing its first-in-class inhibitor of METTL3 is effective as a new therapeutic strategy against AML STORM Therapeutics
28-Apr-2021 Prime Global partners with LLCP for future growth Prime Global
28-Apr-2021 EYEMATE System for Remote Glaucoma Management Obtains FDA Breakthrough Device Designation B3C newswire
28-Apr-2021 Aptar Pharma Names Nordic Semiconductor Key Supplier for Digital Healthcare Solutions Portfolio Aptar Pharma
28-Apr-2021 Proteomics PharmaFluidics Launches Next Generation µPACâ„¢ Technology for Routine Proteomics PharmaFluidics NV
28-Apr-2021 University of Birmingham spinout lands funding for rapid development of fluorescent dyes ChromaTwist Ltd
28-Apr-2021 AlzeCure gets late-breaking abstract on ACD440 in neuropathic pain accepted for presentation AlzeCure
27-Apr-2021 SYNLAB sets final offer price for IPO at EUR 18.00 per share Synlab AG
27-Apr-2021 SYNLAB sets final offer price for IPO at EUR 18.00 per share Synlab AG
27-Apr-2021 Beiersdorf Aktiengesellschaft: Change in the Chair of the Executive Board Beiersdorf Aktiengesellschaft
27-Apr-2021 Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders Epigenomics AG
27-Apr-2021 Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders Epigenomics AG
27-Apr-2021 SOHM, Inc., signs a Mutual Letter of Intent for an Acquisition of Southern California based Pharmaceutical Company Sohm, Inc.